Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-02-04
2010-06-15
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S016700, C514S017400, C514S018700
Reexamination Certificate
active
07737113
ABSTRACT:
Disclosed are novel peptides including antiarrhythmic peptides that have improved stability. Further disclosed are compositions that include such peptides and methods of using the compositions particularly as medicaments.
REFERENCES:
patent: 4775743 (1988-10-01), Mimura et al.
patent: 5817316 (1998-10-01), Sodroski et al.
patent: 19707854 A 1 (1998-09-01), None
patent: 0 214 659 (1987-03-01), None
patent: WO 96/21674 (1996-07-01), None
patent: WO 01/62775 (2001-08-01), None
patent: WO 02/077017 (2002-10-01), None
Lazar et al., Molecular and Cellular Biology, 1988, vol. 8, pp. 1247-1252.
Y. Kohama, et al. “Effect of N-3-(4-Hydroxyphenyl) propionyl Pro-Pro-Gly-Ala-Gly on Calcium-Induced Arrhythmias”, Chemical & Pharmaceutical Bulletin, vol. 36, No. 11, 1988, pp. 4597-4599.
S. Dhein, et al. “Therapeutic Potential of Antiarrhythmic Peptides”, Drugs, vol. 49, No. 6, 1995, pp. 851-855.
B. Kundu “Synthesis, conformational features and biological activity of Pro-3 antiarrhythmic peptide”, Collection of Czechoslovak Chemical Communications, vol. 54, No. 3, 1989, pp. 760-771.
B. Weinstein “Chemistry and Biochemistry of Amino Acids, Peptides and Proteins” 1982, Marcel Dekker Inc., New York and Basel, p. 357.
Chorev et al., “Recent developments in retro peptides and proteins—an ongoing topochemical exploration”TIBTECH13:438-445, (1995).
Dhein et al,, “A new synthetic antiarrhythmic peptide reduces dispersion of epicardical activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia”Naunyn-Schmiedeberg's Arch Pharmacol350:174-184, (1994).
Grover et al., “Spatial structure determination of antiarrhythmic peptide using nuclear magnetic resonance spectrospcopy”Peptides19:1725-1729, (1998).
Office Action in Japanese Application No. 2001-562556 mailed Sep. 16, 2008 and English language translation.
Holstein-Rathlou Niels-Henrik
Jorgensen Niklas Rye
Kjolbye Anne Louise
Larsen Bjarne Due
Martins James B.
Bieker-Brady Kristina
Clark & Elbing LLP
Tate Christopher R.
Teller Roy
Zealand Pharma A/S
LandOfFree
Antiarrhythmic peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiarrhythmic peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiarrhythmic peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4249292